Compounds > troleandomycin
Page last updated: 2024-09-05

troleandomycin and paromomycin

troleandomycin has been researched along with paromomycin in 4 studies

Compound Research Comparison

Studies
(troleandomycin)		Trials
(troleandomycin)		Recent Studies (post-2010)
(troleandomycin)		Studies
(paromomycin)		Trials
(paromomycin)		Recent Studies (post-2010) (paromomycin)
56926231,42290292

Protein Interaction Comparison

ProteinTaxonomytroleandomycin (IC50)paromomycin (IC50)
30S ribosomal protein S6Escherichia coli K-120.0355
30S ribosomal protein S7Escherichia coli K-120.0355
50S ribosomal protein L15Escherichia coli K-120.0355
50S ribosomal protein L10Escherichia coli K-120.0355
50S ribosomal protein L11Escherichia coli K-120.0355
50S ribosomal protein L7/L12Escherichia coli K-120.0355
50S ribosomal protein L19Escherichia coli K-120.0355
50S ribosomal protein L1Escherichia coli K-120.0355
50S ribosomal protein L20Escherichia coli K-120.0355
50S ribosomal protein L27Escherichia coli K-120.0355
50S ribosomal protein L28Escherichia coli K-120.0355
50S ribosomal protein L29Escherichia coli K-120.0355
50S ribosomal protein L31Escherichia coli K-120.0355
50S ribosomal protein L31 type BEscherichia coli K-120.0355
50S ribosomal protein L32Escherichia coli K-120.0355
50S ribosomal protein L33Escherichia coli K-120.0355
50S ribosomal protein L34Escherichia coli K-120.0355
50S ribosomal protein L35Escherichia coli K-120.0355
50S ribosomal protein L36Escherichia coli K-120.0355
30S ribosomal protein S10Escherichia coli K-120.0355
30S ribosomal protein S11Escherichia coli K-120.0355
30S ribosomal protein S12Escherichia coli K-120.0355
30S ribosomal protein S13Escherichia coli K-120.0355
30S ribosomal protein S16Escherichia coli K-120.0355
30S ribosomal protein S18Escherichia coli K-120.0355
30S ribosomal protein S19Escherichia coli K-120.0355
30S ribosomal protein S20Escherichia coli K-120.0355
30S ribosomal protein S2Escherichia coli K-120.0355
30S ribosomal protein S3Escherichia coli K-120.0355
30S ribosomal protein S4Escherichia coli K-120.0355
30S ribosomal protein S5Escherichia coli K-120.0355
30S ribosomal protein S8Escherichia coli K-120.0355
30S ribosomal protein S9Escherichia coli K-120.0355
50S ribosomal protein L13Escherichia coli K-120.0355
50S ribosomal protein L14Escherichia coli K-120.0355
50S ribosomal protein L16Escherichia coli K-120.0355
50S ribosomal protein L23Escherichia coli K-120.0355
30S ribosomal protein S15Escherichia coli K-120.0355
50S ribosomal protein L17Escherichia coli K-120.0355
50S ribosomal protein L21Escherichia coli K-120.0355
50S ribosomal protein L30Escherichia coli K-120.0355
50S ribosomal protein L6Escherichia coli K-120.0355
30S ribosomal protein S14Escherichia coli K-120.0355
30S ribosomal protein S17Escherichia coli K-120.0355
30S ribosomal protein S1Escherichia coli K-120.0355
50S ribosomal protein L18Escherichia coli K-120.0355
50S ribosomal protein L2Escherichia coli K-120.0355
50S ribosomal protein L3Escherichia coli K-120.0355
50S ribosomal protein L24Escherichia coli K-120.0355
50S ribosomal protein L4Escherichia coli K-120.0355
50S ribosomal protein L22Escherichia coli K-120.0355
50S ribosomal protein L5Escherichia coli K-120.0355
30S ribosomal protein S21Escherichia coli K-120.0355
50S ribosomal protein L25Escherichia coli K-120.0355
50S ribosomal protein L36 2Escherichia coli K-120.0355

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
De Rossi, P; Isaacson, P; Lightbown, JW1
MARTIN, WJ1

Reviews

1 review(s) available for troleandomycin and paromomycin

ArticleYear
NEWER ANTIMICROBIAL AGENTS HAVING CURRENT OR POTENTIAL CLINICAL APPLICATION.
    The Medical clinics of North America, 1964, Volume: 48

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cephalothin; Colistin; Cycloserine; Demeclocycline; Erythromycin; Gentamicins; Griseofulvin; Humans; Kanamycin; Methicillin; Novobiocin; Oxacillin; Paromomycin; Penicillin V; Penicillins; Pharmacology; Ristocetin; Staphylococcal Infections; Toxicology; Troleandomycin; Vancomycin

1964

Other Studies

3 other study(ies) available for troleandomycin and paromomycin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
International standards and international reference preparations: amphotericin B, vancomycin, capreomycin, cefalotin, demethylchlortetracycline, gentamycin, gramicidin S, kanamycin and kanamycin B, lincomycin, lymecycline, methacycline, paromomycin, rifam
    Bulletin of the World Health Organization, 1972, Volume: 47, Issue:3

    Topics: Amphotericin B; Anti-Bacterial Agents; Antitubercular Agents; Capreomycin; Cephalothin; Demeclocycline; Gentamicins; International Cooperation; Kanamycin; Leucomycins; Lincomycin; Lymecycline; Methacycline; Paromomycin; Rifamycins; Ristocetin; Troleandomycin; Tyrothricin; Vancomycin; World Health Organization

1972
Antibiotics of limited usefulness.
    The Medical letter on drugs and therapeutics, 1969, Dec-12, Volume: 11, Issue:25

    Topics: Anti-Bacterial Agents; Bacitracin; Dihydrostreptomycin Sulfate; Humans; Novobiocin; Paromomycin; Troleandomycin

1969